229 related articles for article (PubMed ID: 37231269)
1. Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor.
Li Q; Nemecz Á; Aymé G; Dejean de la Bâtie G; Prevost MS; Pons S; Barilone N; Baachaoui R; Maskos U; Lafaye P; Corringer PJ
Cell Mol Life Sci; 2023 May; 80(6):164. PubMed ID: 37231269
[TBL] [Abstract][Full Text] [Related]
2. Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses.
Sanders VR; Millar NS
Pharmacol Res; 2023 May; 191():106759. PubMed ID: 37023990
[TBL] [Abstract][Full Text] [Related]
3. An original potentiating mechanism revealed by the cryo-EM structures of the human α7 nicotinic receptor in complex with nanobodies.
Prevost MS; Barilone N; Dejean de la Bâtie G; Pons S; Ayme G; England P; Gielen M; Bontems F; Pehau-Arnaudet G; Maskos U; Lafaye P; Corringer PJ
Nat Commun; 2023 Sep; 14(1):5964. PubMed ID: 37749098
[TBL] [Abstract][Full Text] [Related]
4. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
Delbart F; Brams M; Gruss F; Noppen S; Peigneur S; Boland S; Chaltin P; Brandao-Neto J; von Delft F; Touw WG; Joosten RP; Liekens S; Tytgat J; Ulens C
J Biol Chem; 2018 Feb; 293(7):2534-2545. PubMed ID: 29237730
[TBL] [Abstract][Full Text] [Related]
5. The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.
Papke RL; Horenstein NA; Kulkarni AR; Stokes C; Corrie LW; Maeng CY; Thakur GA
J Biol Chem; 2014 Feb; 289(7):4515-31. PubMed ID: 24362025
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Characterization of the Novel and Selective
Wang X; Daley C; Gakhar V; Lange HS; Vardigan JD; Pearson M; Zhou X; Warren L; Miller CO; Belden M; Harvey AJ; Grishin AA; Coles CJ; O'Connor SM; Thomson F; Duffy JL; Bell IM; Uslaner JM
J Pharmacol Exp Ther; 2020 May; 373(2):311-324. PubMed ID: 32094294
[TBL] [Abstract][Full Text] [Related]
7. Contrasting properties of α7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors.
Gill JK; Chatzidaki A; Ursu D; Sher E; Millar NS
PLoS One; 2013; 8(1):e55047. PubMed ID: 23383051
[TBL] [Abstract][Full Text] [Related]
8. Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor.
Spurny R; Debaveye S; Farinha A; Veys K; Vos AM; Gossas T; Atack J; Bertrand S; Bertrand D; Danielson UH; Tresadern G; Ulens C
Proc Natl Acad Sci U S A; 2015 May; 112(19):E2543-52. PubMed ID: 25918415
[TBL] [Abstract][Full Text] [Related]
9. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
[TBL] [Abstract][Full Text] [Related]
10. Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
Gill JK; Savolainen M; Young GT; Zwart R; Sher E; Millar NS
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5867-72. PubMed ID: 21436053
[TBL] [Abstract][Full Text] [Related]
11. Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
Collins T; Young GT; Millar NS
Neuropharmacology; 2011 Dec; 61(8):1306-13. PubMed ID: 21820451
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators.
Manetti D; Dei S; Arias HR; Braconi L; Gabellini A; Teodori E; Romanelli MN
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770942
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Targeting of
Papke RL; Horenstein NA
Pharmacol Rev; 2021 Jul; 73(3):1118-1149. PubMed ID: 34301823
[TBL] [Abstract][Full Text] [Related]
14. Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria.
Uspenska K; Lykhmus O; Arias HR; Pons S; Maskos U; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2018 Jun; 99():226-235. PubMed ID: 29704624
[TBL] [Abstract][Full Text] [Related]
15. Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
Faghih R; Gfesser GA; Gopalakrishnan M
Recent Pat CNS Drug Discov; 2007 Jun; 2(2):99-106. PubMed ID: 18221220
[TBL] [Abstract][Full Text] [Related]
16. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
[TBL] [Abstract][Full Text] [Related]
17. Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.
Gill-Thind JK; Dhankher P; D'Oyley JM; Sheppard TD; Millar NS
J Biol Chem; 2015 Feb; 290(6):3552-62. PubMed ID: 25516597
[TBL] [Abstract][Full Text] [Related]
18. Allosteric Agonism of
Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
[TBL] [Abstract][Full Text] [Related]
19. Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant
Stokes C; Garai S; Kulkarni AR; Cantwell LN; Noviello CM; Hibbs RE; Horenstein NA; Abboud KA; Thakur GA; Papke RL
J Pharmacol Exp Ther; 2019 Aug; 370(2):252-268. PubMed ID: 31175218
[TBL] [Abstract][Full Text] [Related]
20. Insights Into the Differential Desensitization of
Papke RL; Stokes C
Mol Pharmacol; 2023 Feb; 103(2):63-76. PubMed ID: 36414373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
